Cardiol Therapeutics Market Risk Adjusted Performance
| CRDL Stock | | | CAD 1.41 -0.02 -1.40% |
This technical indicator view for Market Risk Adjusted Performance organizes signals for Cardiol Therapeutics Class and comparable instruments. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Cardiol Therapeutics has a market cap of 157.47 M, ROE of -3.48%. See
Trending Equities for portfolio-level analysis. This suggests a position in Cardiol Therapeutics Class inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Cardiol Therapeutics Class has current Market Risk Adjusted Performance of 0.0491.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.0491 | |
| ER[a] | = | Expected return on investing in Cardiol Therapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Cardiol Therapeutics Market Risk Adjusted Performance Peers Comparison
Cardiol Market Risk Adjusted Performance Relative To Other Indicators
Cardiol Therapeutics Class takes the leading position in market risk adjusted performance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
357.23 in Maximum Drawdown for each unit of Market Risk Adjusted Performance. The spread between Maximum Drawdown and Market Risk Adjusted Performance for Cardiol Therapeutics Class sits at
357.23 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.